Back to Search Start Over

Mogamulizumab exhibits synergistic activity in combination with allogeneic, IL21- expanded, natural killer (NK) cells against T-cell lymphoma

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.doi...........766912e09dd8597c0736873f4d7a487d
Full Text :
https://doi.org/10.13140/rg.2.2.23884.13449